CDKN2A and esophageal squamous cell carcinoma: In addition, the patients with p16-/HPV-positive squamous cell carcinoma of the esophagus were reported to be associated with better clinical outcome [28, 29] and respond better to chemoradiotherapy than the p16-/HPV-negative patients [30].